Thomas Waldmann

Thomas Waldmann has diverse work experience in business development and project management in the life science industry. Thomas currently holds the position of Director BD at CRELUX since February 2018. Prior to that, they worked at AbCheck s.r.o. as Business Development from January 2016 to December 2017. From February 2014 to December 2015, they were an Independent Consultant and later Partner at INCUBIZZ UG, where they focused on business development and project management. Thomas has also served as Director Business Development at Proteros biostructures GmbH from May 2011 to September 2012. Before that, they held the role of Director, Science & Technology Support - Business Development at Sloning BioTechnology GmbH from 2007 to 2011, and earlier, as Project Technical Lead from 2002 to 2006. Thomas began their career as a Scientific Group Leader at EleGene GmbH from April 2000 to March 2002. Thomas also gained experience as a Scientist at Max-Planck-Institute for Biochemistry and Memorial Sloan-Kettering Cancer Center from 1996 to 1999 and 1996 to 1997, respectively.

Thomas Waldmann earned their Diploma in Biology from the Technical University of Munich in 1994. Thomas then pursued a Ph.D. in Biochemistry at the same university from 1994 to 1996. Later, they obtained an MBA degree from Henley Business School from 2005 to 2010. Furthermore, it is known that they have some affiliation with the Max Planck Society, although specific details of this experience were not provided.